CLINICAL TRIAL: CBT AUGMENTATION OF SSRI TREATMENT FOR GERIATRIC GAD

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。列出的机构是 研究中心，而研究中心不一定是研究者所在的机构。 一项为期56周的多中心研究，旨在评估认知行为疗法作为广泛性焦虑症老年患者（对艾司西酞普兰有部分或完全应答者）的增强和维持策略的疗效，以及艾司西酞普兰维持治疗预防复发的疗效。 目的是检查增加CBT疗程是否会增加缓解率，并导致症状反应和改善对艾司西酞普兰部分反应的老年GAD患者的神经心理功能。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. 56 week multicenter study on the efficacy of Cognitive-Behavioral Therapy as an augmentation and maintenance strategy for older adults with Generalized Anxiety Disorder who are partial or full responders to escitalopram and also on the efficacy of maintenance escitalopram to prevent relapse. Goals are to examine whether adding a course of CBT will increase remission rates and reult in sympotomatic response and improved neuropsychological functioning among older adults with GAD who are partial responders to escitalopram.